Downregulation of microRNAs directs the EMT and invasive potential of anaplastic thyroid carcinomas

Oncogene

Volumn 29, Issue 29, 2010, Pages 4237-4244

  Braun, J ^a   Hoang Vu, C ^a   Dralle, H ^a   Huttelmaier S ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

ATC; EMT; microRNA; SMAD2; TGFb; TGFBR1

Indexed keywords

MEMBRANE PROTEIN; MICRORNA; PROTEIN MIR 21; SMAD2 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; UNCLASSIFIED DRUG;

ANAPLASTIC CARCINOMA; ARTICLE; CANCER INVASION; CELL DIFFERENTIATION; DOWN REGULATION; EPITHELIUM CELL; MESENCHYME CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; THYROID CARCINOMA; UPREGULATION;

CARCINOMA; DOWN-REGULATION; EPITHELIAL CELLS; HOMEODOMAIN PROTEINS; HUMANS; MESODERM; MICRORNAS; NEOPLASM INVASIVENESS; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; REPRESSOR PROTEINS; SMAD2 PROTEIN; THYROID NEOPLASMS; TRANSFORMING GROWTH FACTOR BETA;

EID: 77954956544     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2010.169     Document Type: Article

References (26)

1. Brabant G, Hoang-Vu C, Cetin Y, Dralle H, Scheumann G, Molne J et al (1993). E-cadherin: a differentiation marker in thyroid malignancies. Cancer Res 53: 4987-4993.
2. Bracken CP, Gregory PA, Kolesnikoff N, Bert AG, Wang J, Shannon MF et al (2008). A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchy-mal transition. Cancer Res 68: 7846-7854.
3. Budhu A, Jia HL, Forgues M, Liu CG, Goldstein D, Lam A et al. (2008). Identification of metastasis-related microRNAs in hepato-cellular carcinoma. Hepatology 47: 897-907.
4. Burk U, Schubert J, Wellner U, Schmalhofer O, Vincan E, Spaderna S et al. (2008). A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO Rep 9: 582-589.
5. Cui W, Fowlis DJ, Bryson S, Duffie E, Ireland H, Balmain A et al. (1996). TGFbeta1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice. Cell 86: 531-542.
6. Davis BN, Hilyard AC, Lagna G, Hata A. (2008). SMAD proteins control DROSHA-mediated microRNA maturation. Nature 454: 56-61.
7. Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, Farshid G et al. (2008). The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 10: 593-601.
8. Guzinska-Ustymowicz K, Kemona A. (2005). Transforming growth factor beta can be a parameter of aggressiveness of pT1 colorectal cancer. World J Gastroenterol 11: 1193-1195.
9. He H, Jazdzewski K, Li W, Liyanarachchi S, Nagy R, Volinia S et al. (2005). The role of microRNA genes in papillary thyroid carcinoma. Proc Natl Acad Sci USA 102: 19075-19080.
10. Kim YK, Yu J, Han TS, Park SY, Namkoong B, Kim DH et al. (2009). Functional links between clustered microRNAs: suppression of cell-cycle inhibitors by microRNA clusters in gastric cancer. Nucl Acids Res 37: 1672-1681.
11. Kondo T, Ezzat S, Asa SL. (2006). Pathogenetic mechanisms in thyroid follicular-cell neoplasia. Nat Rev Cancer 6: 292-306.
12. Mercatelli N, Coppola V, Bonci D, Miele F, Costantini A, Guadagnoli M et al. (2008). The inhibition of the highly expressed miR-221 and miR-222 impairs the growth of prostate carcinoma xenografts in mice. PLoS One 3: e4029.
13. Nikiforova MN, Tseng GC, Steward D, Diorio D, Nikiforov YE. (2008). MicroRNA expression profiling of thyroid tumors: biological significance and diagnostic utility. J Clin Endocrinol Metab 93: 1600-1608.
14. Pallante P, Visone R, Ferracin M, Ferraro A, Berlingieri MT, Troncone G et al. (2006). MicroRNA deregulation in human thyroid papillary carcinomas. Endocr Relat Cancer 13: 497-508.
15. Park SM, Gaur AB, Lengyel E, Peter ME. (2008). The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev 22: 894-907.
16. Parkin DM, Bray F, Ferlay J, Pisani P. (2005). Global Cancer Statistics, 2002. CA Cancer J Clin 55: 74-108.
17. Piek E, Moustakas A, Kurisaki A, Heldin CH, ten Dijke P. (1999). TGF-(beta) type I receptor/ALK-5 and Smad proteins mediate epithelial to mesenchymal transdifferentiation in NMuMG breast epithelial cells. J Cell Sci 112(Part 24): 4557-4568.
18. Resnick MB, Schacter P, Finkelstein Y, Kellner Y, Cohen O. (1998). Immunohistochemical analysis of p27/kip1 expression in thyroid carcinoma. Mod Pathol 11: 735-739.
19. Rocha AS, Soares P, Fonseca E, Cameselle-Teijeiro J, Oliveira MC, Sobrinho-Simoes M. (2003). E-cadherin loss rather than beta-catenin alterations is a common feature of poorly differentiated thyroid carcinomas. Histopathology 42: 580-587.
20. Safina A, Vandette E, Bakin AV. (2007). ALK5 promotes tumor angiogenesis by upregulating matrix metalloproteinase-9 in tumor cells. Oncogene 26: 2407-2422.
21. Schwertheim S, Sheu SY, Worm K, Grabellus F, Schmid KW. (2009). Analysis of deregulated miRNAs is helpful to distinguish poorly differentiated thyroid carcinoma from papillary thyroid carcinoma. Horm Metab Res 41: 475-481.
22. Shao ES, Lin L, Yao Y, Bostrom KI. (2009). Expression of vascular endothelial growth factor is coordinately regulated by the activin-like kinase receptors 1 and 5 in endothelial cells. Blood 114: 2197-2206.
23. Vasko V, Espinosa AV, Scouten W, He H, Auer H, Liyanarachchi S et al. (2007). Gene expression and functional evidence of epithelial-to-mesenchymal transition in papillary thyroid carcinoma invasion. Proc Natl Acad Sci USA 104: 2803-2808.
24. Visone R, Pallante P, Vecchione A, Cirombella R, Ferracin M, Ferraro A et al. (2007). Specific microRNAs are downregulated in human thyroid anaplastic carcinomas. Oncogene 26: 7590-7595.
25. Weber F, Teresi RE, Broelsch CE, Frilling A, Eng C. (2006). A limited set of human MicroRNA is deregulated in follicular thyroid carcinoma. J Clin Endocrinol Metab 91: 3584-3591.
26. Zhu S, Wu H, Wu F, Nie D, Sheng S, Mo YY. (2008). MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. Cell Res 18: 350-359.